Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Location
245 First Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 191 % +46.3%
Quick Ratio 16.8 % -33.3%
Debt-to-equity 2.58K %
Return On Equity -138 % -206%
Return On Assets -5.13 % +75.1%
Operating Margin 7.88 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 265M shares +21.6%
Common Stock, Shares, Outstanding 265M shares +25.4%
Entity Public Float 211M USD +24.3%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 265M shares +25.9%
Weighted Average Number of Shares Outstanding, Diluted 274M shares +30.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 225M USD +32.5%
Cost of Revenue 47.3M USD -23.1%
Research and Development Expense 47.5M USD +32.9%
Operating Income (Loss) 17.7M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.3M USD +66.8%
Income Tax Expense (Benefit) 615K USD
Net Income (Loss) Attributable to Parent -15.9M USD +65.4%
Earnings Per Share, Basic 0 USD/shares +68.2%
Earnings Per Share, Diluted 0 USD/shares +68.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 166M USD +389%
Accounts Receivable, after Allowance for Credit Loss, Current 66.2M USD +106%
Inventory, Net 18.6M USD -9.03%
Other Assets, Current 5.33M USD -14.2%
Assets, Current 258M USD +158%
Property, Plant and Equipment, Net 1.47M USD -41.8%
Operating Lease, Right-of-Use Asset 4.84M USD -48%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 59M USD 0%
Other Assets, Noncurrent 40.5M USD +49.1%
Assets 364M USD +75.8%
Accounts Payable, Current 10.1M USD -25.2%
Employee-related Liabilities, Current 9.32M USD +23.1%
Accrued Liabilities, Current 106M USD +104%
Contract with Customer, Liability, Current 3.88M USD
Liabilities, Current 133M USD +103%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 5M USD +5.82%
Liabilities 323M USD +25.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD 0%
Retained Earnings (Accumulated Deficit) -1.67B USD -0.96%
Stockholders' Equity Attributable to Parent 41.6M USD
Liabilities and Equity 364M USD +75.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.6M USD +30.1%
Net Cash Provided by (Used in) Financing Activities 74.9M USD +306%
Net Cash Provided by (Used in) Investing Activities 154K USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 265M shares +25.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 61.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 168M USD +371%
Deferred Tax Assets, Valuation Allowance 388M USD +6.15%
Deferred Tax Assets, Gross 391M USD +3.77%
Operating Lease, Liability 4.94M USD -51.7%
Depreciation 314K USD -13.7%
Payments to Acquire Property, Plant, and Equipment 18K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.9M USD +65.4%
Lessee, Operating Lease, Liability, to be Paid 5.07M USD -53.3%
Operating Lease, Liability, Current 4.94M USD -6.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.61M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.61M USD -37.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 137K USD -78.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD -56.4%
Deferred Tax Assets, Operating Loss Carryforwards 292M USD +0.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.57M USD -60.9%
Operating Lease, Payments 6M USD +7.14%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 27M USD -25%
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -71%
Share-based Payment Arrangement, Expense 9.78M USD +28.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%